{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:57:18Z","timestamp":1761238638376,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008728","name":"Japan Research Foundation for Clinical Pharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jpsychires.2019.06.019","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T18:31:13Z","timestamp":1561401073000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Circadian patterns of hallucinatory experiences in patients with schizophrenia: Potentials for chrono-pharmacology"],"prefix":"10.1016","volume":"117","author":[{"given":"Teruki","family":"Koizumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takefumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil Sasidharan","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert R.","family":"Bies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyoshi","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimio","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2019.06.019_bib1","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2019.06.019_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0091270007310385","article-title":"Sex, race, and smoking impact olanzapine exposure","volume":"48","author":"Bigos","year":"2008","journal-title":"J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2019.06.019_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1600-079X.2003.00114.x","article-title":"Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: modulation by light","volume":"36","author":"Castaneda","year":"2004","journal-title":"J. Pineal Res."},{"issue":"15","key":"10.1016\/j.jpsychires.2019.06.019_bib4","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2165\/00003088-200241150-00002","article-title":"Clinical pharmacokinetics of sertraline","volume":"41","author":"DeVane","year":"2002","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.jpsychires.2019.06.019_bib5","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/archpsyc.1990.01810180058009","article-title":"Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia","volume":"47","author":"Doran","year":"1990","journal-title":"Arch. Gen. Psychiatr."},{"issue":"6","key":"10.1016\/j.jpsychires.2019.06.019_bib6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance","volume":"33","author":"Endicott","year":"1976","journal-title":"Arch. Gen. Psychiatr."},{"issue":"1 Suppl. 1","key":"10.1016\/j.jpsychires.2019.06.019_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004714-199502001-00004","article-title":"Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients","volume":"15","author":"Farde","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2019.06.019_bib8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.STR.32.3.613","article-title":"Is there a temporal pattern in the occurrence of subarachnoid hemorrhage in the southern hemisphere? Pooled data from 3 large, population-based incidence studies in Australasia, 1981 to 1997","volume":"32","author":"Feigin","year":"2001","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jpsychires.2019.06.019_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2125.2008.03276.x","article-title":"Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study","volume":"66","author":"Feng","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.jpsychires.2019.06.019_bib10","first-page":"20","article-title":"Pretreatment status and its relationship to the length of drying-out period","volume":"12","author":"Guy","year":"1976","journal-title":"Psychopharmacol. Bull."},{"issue":"3","key":"10.1016\/j.jpsychires.2019.06.019_bib11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1081\/CBI-100103970","article-title":"Circadian rhythm of double (rate-pressure) product in healthy normotensive young subjects","volume":"18","author":"Hermida","year":"2001","journal-title":"Chronobiol. Int."},{"issue":"Suppl. 12","key":"10.1016\/j.jpsychires.2019.06.019_bib12","first-page":"5","article-title":"Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary","volume":"64","author":"Kane","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2019.06.019_bib13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","article-title":"Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia","volume":"157","author":"Kapur","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2019.06.019_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"9","key":"10.1016\/j.jpsychires.2019.06.019_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/psp4.12217","article-title":"Determination of plasma concentration reference ranges for risperidone and paliperidone","volume":"6","author":"Korell","year":"2017","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"13","key":"10.1016\/j.jpsychires.2019.06.019_bib16","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/jama.1987.03400130103041","article-title":"Delirium (acute confusional states)","volume":"258","author":"Lipowski","year":"1987","journal-title":"J. Am. Med. Assoc."},{"issue":"1\u20133","key":"10.1016\/j.jpsychires.2019.06.019_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jad.2006.12.001","article-title":"Diurnal mood variation in depression: a signal of disturbed circadian function?","volume":"102","author":"Murray","year":"2007","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jpsychires.2019.06.019_bib18","first-page":"212","article-title":"Dopamine D2\/3 receptor occupancy following dose reduction is predictable with minimal plasma antipsychotic concentrations: an open-label clinical trial","volume":"42","author":"Nakajima","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.jpsychires.2019.06.019_bib19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/FTD.0b013e31819c7037","article-title":"Clozapine exposure and the impact of smoking and gender: a population pharmacokinetic study","volume":"31","author":"Ng","year":"2009","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.jpsychires.2019.06.019_bib20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1067\/mai.2003.65","article-title":"Circadian variation of sputum inflammatory cells in mild asthma","volume":"111","author":"Panzer","year":"2003","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.jpsychires.2019.06.019_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fnagi.2017.00253","article-title":"Does tinnitus depend on time-of-day? An ecological momentary assessment study with the \"TrackYourTinnitus\" application","volume":"9","author":"Probst","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.jpsychires.2019.06.019_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF01061728","article-title":"Estimation of population characteristics of pharmacokinetic parameters from routine clinical data","volume":"5","author":"Sheiner","year":"1977","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.jpsychires.2019.06.019_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand. Suppl."},{"issue":"7","key":"10.1016\/j.jpsychires.2019.06.019_bib24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1055\/s-0035-1565070","article-title":"Predicting plasma olanzapine concentration following a change in dosage: a population pharmacokinetic study","volume":"48","author":"Tsuboi","year":"2015","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2019.06.019_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/FTD.0b013e3182489a6f","article-title":"Predicting plasma concentration of risperidone associated with dosage change: a population pharmacokinetic study","volume":"34","author":"Uchida","year":"2012","journal-title":"Ther. Drug Monit."},{"issue":"4","key":"10.1016\/j.jpsychires.2019.06.019_bib26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/JCP.0b013e3182214aad","article-title":"Dopamine D2 receptor occupancy and clinical effects: a systematic review and pooled analysis","volume":"31","author":"Uchida","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2019.06.019_bib27","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/JCP.0b013e318218d339","article-title":"Predicting dopamine D(2) receptor occupancy from plasma levels of antipsychotic drugs: a systematic review and pooled analysis","volume":"31","author":"Uchida","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"year":"1992","series-title":"The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines","author":"World Health Organization","key":"10.1016\/j.jpsychires.2019.06.019_bib28"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395619305606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395619305606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:11:53Z","timestamp":1758366713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395619305606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":28,"alternative-id":["S0022395619305606"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2019.06.019","relation":{},"ISSN":["0022-3956"],"issn-type":[{"type":"print","value":"0022-3956"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circadian patterns of hallucinatory experiences in patients with schizophrenia: Potentials for chrono-pharmacology","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2019.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}